Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-02
2011-08-02
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S184000, C546S192000, C546S211000, C546S268100, C546S275100, C546S350000, C546S325000, C514S315000, C514S317000, C514S403000, C514S406000
Reexamination Certificate
active
07989475
ABSTRACT:
The present invention relates to substituted pyrazoles, compositions containing such compounds and methods of treatment The compounds are glucagon receptor antagonists and thus are useful for treating, preventing or delaying the onset of type 2 diabetes mellitus.
REFERENCES:
patent: 5670503 (1997-09-01), Kawai et al.
patent: 5776954 (1998-07-01), de Laszlo et al.
patent: 6057335 (2000-05-01), Fukami et al.
patent: 6218431 (2001-04-01), Schoen et al.
patent: 6420427 (2002-07-01), Takahashi et al.
patent: 6440963 (2002-08-01), Leonardi et al.
patent: 6503949 (2003-01-01), Lau et al.
patent: 6562807 (2003-05-01), Kodra et al.
patent: 6613942 (2003-09-01), Ling et al.
patent: 6762318 (2004-07-01), Kodra et al.
patent: 6790810 (2004-09-01), Yanagi et al.
patent: 6881746 (2005-04-01), Lau et al.
patent: 7572922 (2009-08-01), Parmee et al.
patent: 7598285 (2009-10-01), Parmee et al.
patent: 7625938 (2009-12-01), Brockunier et al.
patent: 2005/0171196 (2005-08-01), Fujii et al.
patent: 2005/0272794 (2005-12-01), Parmee et al.
patent: 2006/0084681 (2006-04-01), Parmee et al.
patent: 2007/0088070 (2007-04-01), Parmee et al.
patent: 1 400 243 (2004-03-01), None
patent: 2124517 (1999-01-01), None
patent: 2001110360 (2003-03-01), None
patent: 97/16442 (1997-05-01), None
patent: 98/04528 (1998-02-01), None
patent: 98/21957 (1998-05-01), None
patent: 98/22108 (1998-05-01), None
patent: 98/22109 (1998-05-01), None
patent: 98/47509 (1998-10-01), None
patent: 99/32448 (1999-07-01), None
patent: 00/15229 (2000-03-01), None
patent: 00/39088 (2000-07-01), None
patent: 00/69810 (2000-11-01), None
patent: 02/00612 (2002-01-01), None
patent: 02/08188 (2002-01-01), None
patent: 02/40444 (2002-05-01), None
patent: 03/048109 (2003-06-01), None
patent: 03/051357 (2003-06-01), None
patent: 03/053938 (2003-07-01), None
patent: 03/064404 (2003-08-01), None
patent: 03/097619 (2003-11-01), None
patent: 2004/002480 (2004-01-01), None
patent: 2004/091589 (2004-01-01), None
patent: 2004/050039 (2004-06-01), None
patent: 2004/069158 (2004-08-01), None
patent: 2004/092146 (2004-10-01), None
patent: 2004/100875 (2004-11-01), None
patent: 2005/121097 (2005-12-01), None
M. J. Burk et al., “Catalytic Asymmetric Reductive Amination of Ketones via Highly Enantioselective Hydrogenation of the C=N. Double Bond”, Tetrahedron, vol. 50, No. 15, pp. 4399-4428 (1994).
Kurukulasuriya et al., “Biaryl amide glucagon receptor antagonists”, Bioorganic & Medicinal Chemistry Letter, vol. 114, pp. 2047-2050 (2004).
Merck & Co., Inc., U.S. Appl. No. 60/442,828, filed Jan. 27, 2003.
Merck & Co., Inc., U.S. Appl. No. 60/577,116, filed Jun. 4, 2004.
Yellin et al., Caplus, 1983: 72126.
Colarusso et al., Caplus, 2002: 777963.
Beeson Teresa
Parmee Emma
Raghavan Subharekha
Shen Dong-Ming
Billups Richard C.
Merck Sharp & Dohme Corp.
Shameem Golam M
Struse Heidi M.
LandOfFree
Substituted pyrazoles, compositions containing such... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrazoles, compositions containing such..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrazoles, compositions containing such... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2727569